Korean J Nucl Med.
2000 Jun;34(3):243-251.
Radioimmunoscintigraphy Using (99m)Tc-anti-CEA F(ab')(2) Fragment in Rectal
Cancer and a Pilot Study for Radioimmunoguided Surgery
Abstract
-
PURPOSE: This prospective study was performed to evaluate the usefulness of preoperative
radioimmu-noscintigraphy and intraoperative scintimetric examination (radioimmunoguided
surgery: RIGS) using (99m)Tc-anti-CEA F(ab')(2), fragment.
MATERIALS AND METHODS
Nineteen patients with rectal cancer underwent preoperative whole
body planar scintigraphy at 4 hours after injection of (99m)Tc-anti-CEA F(ab')(2), fragment
and SPECT imaging at 18 hours. Surgical operation was performed at 24 hours after injection.
During laparotomy, radioactivities from intraabdominal viscera were measured by gamma probe.
The radioac-tivities from excised tumor and lymph nodes were also measured and compared with
pathology.
RESULTS
All nineteen patients were confirmed to have adenocarcinomas in the rectum.
Twenty-seven of 97 excised lymph node groups had metastasis and 2 patients had liver
metastasis in pathology. Preoperative radioim- munoscintigraphy detected primary tumors
in 11 patients (sensitivity 55%) and it couId not detect any lymph nodes or liver metastasis.
All patients showed high radioactivity in the kidneys, liver, spleen, and major vessels in
intraoperative measurement by gamma probe, and tumor activity was not discriminated from
background activity. However, ra4ioactivity from excised tumor was higher than normal rectum
(T/B ratio; 3.47+/-2.25). When excised lymph node activity/background activity ratio > 1,5
was considered as positive criteria of metastasis, sensitivity, specificity, positive and
negative predictive values were 78.6%, 73.9%, 55.0% and 89.5%, respectively.
CONCLUSION
Radioimmunoscintigraphy using (99m)Tc-anti-CEA F(ab')(2). has no additional
value for preoperative staging and use of early RIGS using (99m)Tc-anti-CEA F(ab')(2)is
inappropriate. For early RIGS using (99m)Tc labeled antibodies in rectal cancer patients,
further development of more specific antibodies and methods to reduce background activity
are needed.